Itron, INC

Market Movers (8-K)

See all →
NASDAQ
Itron, Inc. announced third quarter 2026 financial results, showing a 3% increase in revenue to $599 million and earnings exceeding expectations, driven by growth in its Outcomes segment and strong adjusted EBITDA.
Better than expected
NASDAQ
Itron announced its second quarter 2026 financial results, reporting revenue of $563 million, a 7% decrease year-over-year, but highlighted record gross margin and earnings exceeding expectations, leading to an increased full-year earnings outlook.
NASDAQ
Itron, Inc. announced first quarter 2026 financial results, showing revenue of $587 million and adjusted EBITDA increase of 5%, with free cash flow up 18%.
NASDAQ
Itron, Inc. disclosed a cybersecurity incident on April 13, 2026, where an unauthorized third party accessed certain company systems, with ongoing investigations and expected insurance reimbursements.
NASDAQ
Itron, Inc. announced the pricing of its $700 million 0.00% Convertible Senior Notes due 2032, upsized to $805 million with the full exercise of an additional purchase option, alongside a common stock repurchase and capped call transactions.
Capital raise
NASDAQ
Itron, Inc. announced robust financial results for the fourth quarter and full year ended December 31, 2025, driven by strong Outcomes growth and strategic acquisitions.
Delay expected
Better than expected

Quarterly Earnings (10-Q)

See all →
NASDAQ
Itron Inc. announced its third-quarter 2026 financial results, showcasing a 3% increase in total revenues to $599.3 million and a significant improvement in gross margin to 40.9%.
Capital raise
NASDAQ
Itron, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting a decrease in total revenues but an improvement in gross margin.
Capital raise
NASDAQ
Itron, Inc. announced its first quarter 2026 financial results, showing a decrease in total revenues but an increase in gross margin, alongside the significant impact of the Locusview acquisition.
Worse than expected
Capital raise
NASDAQ
Itron, Inc. reports a decrease in Q3 2025 revenues but significant gross margin expansion, alongside a strategic acquisition of Urbint, Inc. to boost AI-powered solutions.
NASDAQ
Itron, Inc. delivered robust financial results for the second quarter of 2025, showcasing significant increases in net income, EPS, and gross margins, driven by growth in its high-value Outcomes segment and strong operational cash generation.
Better than expected
Capital raise
NASDAQ
Itron's Q1 2025 shows a slight revenue increase and a significant jump in net income, driven by improved gross margins and effective cost management.
Better than expected

Annual Reports (10-K)

NASDAQ
Itron, Inc. announced a significant increase in net income and EPS for 2025, driven by improved margins and strategic acquisitions in resilience and digital construction management.
Better than expected
Delay expected
Capital raise
NASDAQ
Itron's 2024 annual report reveals a significant increase in revenue and net income, driven by growth across all operating segments and improved operational efficiency.
Capital raise
Better than expected
NASDAQ
Itron implements a clawback policy to recover erroneously awarded compensation from executive officers in the event of accounting restatements, aligning with regulatory requirements.

Insider Trading (Form 4)

See all →
NASDAQ
Sheri Savage, a Director of Itron, Inc., received 608 shares of common stock on October 1, 2026.
NASDAQ
Santiago Perez, a Director of Itron, Inc., received 608 shares of common stock on October 1, 2026.
NASDAQ
Sanjay Mirchandani, a Director of Itron, Inc., received 608 shares of common stock on October 1, 2026.
NASDAQ
Timothy M Leyden, a Director of Itron, Inc., received 243 shares of common stock on October 1, 2026.
NASDAQ
Jerome J. Lande, a Director of Itron, Inc., received 608 shares of common stock on October 1, 2026.
NASDAQ
Frank M Jaehnert, a Director of Itron, Inc., received 608 shares of common stock on October 1, 2026.

Proxy Statements (Def-14A)

NASDAQ
Itron's 2026 proxy statement details the upcoming virtual annual meeting, proposals for director elections, executive compensation, and auditor ratification, while highlighting robust 2025 financial and operational achievements.
Better than expected
NASDAQ
Itron, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) related to its upcoming shareholder meeting.
NASDAQ
Itron's proxy statement outlines proposals for the 2025 annual meeting, including increasing authorized shares, making technical amendments to the articles of incorporation, and adding indemnification provisions for directors and officers.
Better than expected
Capital raise
NASDAQ
Itron, Inc. has filed a definitive proxy statement with the SEC regarding its upcoming shareholder meeting.
NASDAQ
Itron's proxy statement outlines proposals for the 2024 annual meeting, including the election of directors, approval of executive compensation, and an amendment to the stock incentive plan.
Better than expected

Schedule 13G - Passive Investments

NASDAQ
Vanguard Capital Management has reported beneficial ownership of 5.33% of Itron Inc.'s common stock as of March 31, 2026.
NASDAQ
Vanguard Portfolio Management has reported a beneficial ownership of 7.97% in Itron Inc. common stock as of March 31, 2026.
NASDAQ
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Itron Inc. following an internal realignment.
NASDAQ
Invesco Ltd. has filed an amendment to its Schedule 13G, reporting beneficial ownership of 4.9% of Itron Inc.'s common stock.
NASDAQ
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 15.2% passive beneficial ownership stake in Itron, Inc.